
    
      Participation to the trial will be proposed to the patient by the investigator in charge of
      the analgesic irradiation during the preliminary scanner session that will be held before
      radiotherapy session(s). Patients with a VAS≤ 3 will be excluded.

      PecFent and Placebo will be delivered by Archimedes Pharma When starting the radiotherapy
      session(s) (2 days after the preliminary scanner session), the medic will collect the patient
      signed informed consent, will deliver the treatment 1 dose of fentanyl transmucosal (Pecfent®
      ) 100µg in naive patients or 1 dose of Pecfent® 200µg in patient with a stable opioid
      background pain treatment or placebo) and will collect pain intensity value with a patient
      VAS collected before and at the end of the radiotherapy session. Finally patient &
      radiotherapists global satisfaction will be collected An assessment a week the end of the
      radiotherapy session will be assessed by investigator consisting in a Patient global
      satisfaction

      Study follow up:

      Patients will receive a phone call a week after the radiotherapy session to collect patient
      global satisfaction score related with the global management of the radiotherapy session
    
  